QDRO
← Ingredients

Antibacterial · Zinc Oxide · CAS 1314-13-2

Оксид цинка

ZnO

ZnO is a mineral antibacterial agent with a dual mechanism: it disrupts bacterial cell membranes and neutralizes volatile sulfur compounds — the primary cause of bad breath. Effective at concentrations from 0.5%.

QDRO position

We use it

Used in select formulas as an antibacterial and deodorizing agent. Synergizes with zinc citrate.

Effective concentration

0.5–2%

Typical on market: 0.5–1%

Оксид цинка

What It Is

Zinc oxide (ZnO) is an inorganic compound that occurs naturally as the mineral zincite, but the ZnO used in oral care is always synthetically produced. It is a white, amorphous powder that is practically insoluble in water, with amphiphilic properties — it reacts with both acids and bases. Molecular weight: 81.4 g/mol.

In dentistry, ZnO has been used for decades — most notably in zinc oxide–eugenol (ZOE) cements for temporary fillings. Modern oral care has revived interest in ZnO, particularly in nanoparticle form (ZnO NPs), which offers a dramatically higher surface-to-volume ratio and correspondingly greater biological activity at lower concentrations.

In consumer products (toothpastes, mouthrinses), conventional (non-nano) ZnO is used at 0.5–2% for its antibacterial, deodorizing, and mild abrasive effects.

How It Works

Antibacterial Mechanism

ZnO acts against oral bacteria through three parallel pathways:

1. Ion release. In aqueous environments, ZnO partially dissolves and releases Zn²⁺ ions. These cations enter bacterial cells and competitively displace functional metals from enzyme active sites — particularly iron- and magnesium-dependent enzymes involved in cellular respiration and DNA replication.

2. Membrane disruption. ZnO particles (and especially nanoparticles) make direct contact with bacterial cell walls. The high surface area creates localized mechanical stress on the lipid bilayer, causing membrane perforation, leakage of intracellular contents (K⁺, proteins, enzymes), and irreversible metabolic failure.

3. Oxidative stress. Under light exposure, ZnO generates reactive oxygen species (ROS) — primarily hydroxyl radicals (·OH) and superoxide anions (O₂·⁻) — which damage bacterial lipids, proteins, and DNA. This pathway is more pronounced under UV exposure than in the oral cavity under normal conditions.

A 2025 study in Biomolecules (PMID 39766327) documented all three mechanisms against Streptococcus mutans specifically. ZnO NPs inhibited S. mutans growth and biofilm formation dose-dependently, with a minimum inhibitory concentration (MIC) of 0.5 mg/mL. A systematic review (Freires et al., 2018, PMID 30202164) covering 23 studies found MIC values ranging from 0.39 to 500 µg/mL, with smaller particles consistently showing greater activity.

Deodorizing Mechanism

Oral malodor is 80–90% caused by volatile sulfur compounds (VSCs): hydrogen sulfide (H₂S), methyl mercaptan (CH₃SH), and dimethyl sulfide. These are produced by anaerobic gram-negative bacteria — primarily Fusobacterium nucleatum and Prevotella intermedia — during protein degradation.

Zn²⁺ ions have high chemical affinity for sulfur. The deodorizing mechanism is twofold (Brunette et al., 2018, PMID 29364345):

  1. Direct binding: Zn²⁺ reacts with thiol groups (-SH) and gaseous H₂S to form insoluble zinc sulfides (ZnS). The odor is chemically neutralized, not masked.
  2. Bacterial suppression: Zn²⁺ simultaneously inhibits the growth of VSC-producing anaerobes, reducing odor production at the source.

Young et al. (2003, PMID 12974683) demonstrated a significant dose- and time-dependent anti-VSC effect in vivo. At Zn²⁺ concentrations ≥0.3%, statistically significant odor reduction was maintained for up to 3 hours post-application.

Clinical Evidence

A 6-week randomized controlled study with a zinc-containing toothpaste showed reductions of 13.4% in gingivitis, 17.0% in dental plaque, and 55.3% in gingival bleeding compared to a fluoride control. A double-blind trial with 2% zinc citrate toothpaste (PMID 39497343) confirmed reduced gingival index, less bleeding, and significantly lower levels of F. nucleatum, P. intermedia, and P. gingivalis in dental plaque over 3 months.

What works well:

  • Antibacterial activity against cariogenic bacteria (S. mutans, S. sobrinus)
  • Biofilm inhibition at achievable toothpaste concentrations
  • VSC neutralization / halitosis control — the most clinically robust effect
  • Synergy with zinc citrate, CPC, and EGCG

What does not work:

  • Deep decontamination of periodontal pockets (ZnO from paste does not reach >2–3 mm depth)
  • Long-term residual antibacterial effect — unlike CPC or chlorhexidine, ZnO lacks substantivity; the effect is limited to brushing time plus a few hours
  • Alkaline formulations above pH 7.5 reduce Zn²⁺ bioavailability, diminishing antibacterial and deodorizing efficacy

Safety

FDA: ZnO has GRAS (Generally Recognized as Safe) status as a food additive and nutrient. Approved as an OTC active ingredient for skin protectant products.

EU: Approved as colorant CI 77947 under the EU Cosmetics Directive. The SCCS confirmed nano-ZnO is safe for dermal use. No specific oral concentration limits beyond standard cosmetic safety guidelines.

CIR: The Expert Panel deferred evaluation to FDA given ZnO's extensive regulatory history. Zinc salts were confirmed safe in the 2024 final report (Scott et al.).

Toxicology: LD₅₀ (rat, oral) >5000 mg/kg. Zinc is an essential micronutrient (recommended daily intake: 8–11 mg for adults); the contribution from toothpaste is negligible. Contact sensitization is extremely rare and typically attributed to raw material impurities, not ZnO itself.

QDRO uses conventional (non-nano) ZnO in consumer products pending a more complete oral bioavailability dataset for nanoparticle forms.


References:

  • Kashibuchi N et al. (2021). Mechanism of Action of Zinc Oxide Nanoparticles as an Antibacterial Agent Against Streptococcus mutans. Biomolecules. PMID: 39766327
  • Freires IA et al. (2018). A systematic review on antibacterial activity of zinc against Streptococcus mutans. Eur J Dent. PMID: 30202164
  • Brunette DM et al. (2018). Two mechanisms of oral malodor inhibition by zinc ions. Oral Dis. PMID: 29364345
  • Young A et al. (2003). Inhibition of orally produced volatile sulfur compounds by zinc, chlorhexidine or cetylpyridinium chloride — effect of concentration. Eur J Oral Sci. PMID: 12974683
  • Deng F et al. (2024). Effects of Toothpaste Containing 2% Zinc Citrate on Gingival Health and Three Related Bacteria — A Randomized Double-Blind Study. J Periodontol. PMID: 39497343